Results from a cervical cancer screening program in Samsun, Turkey

Abstract Background Cervical cancer is a preventable disease. This study aimed to share the results of the national cervical cancer screening program performed in primary health care institutions in Samsun between 2015 and 2019. Methods Women aged 30–65 years who were screened for cervical cancer in...

Full description

Bibliographic Details
Main Authors: Hatice Nilden Arslan, Muhammet Ali Oruc
Format: Article
Language:English
Published: BMC 2022-08-01
Series:BMC Women's Health
Subjects:
Online Access:https://doi.org/10.1186/s12905-022-01916-6
_version_ 1798038013952917504
author Hatice Nilden Arslan
Muhammet Ali Oruc
author_facet Hatice Nilden Arslan
Muhammet Ali Oruc
author_sort Hatice Nilden Arslan
collection DOAJ
description Abstract Background Cervical cancer is a preventable disease. This study aimed to share the results of the national cervical cancer screening program performed in primary health care institutions in Samsun between 2015 and 2019. Methods Women aged 30–65 years who were screened for cervical cancer in screening centers of Samsun between January 01, 2015, and December 31, 2019, were included in this descriptive study. The data were obtained from the automation program of the “National Human Papilloma Virus (HPV) Laboratory Application” used by the Provincial Directorate of Health Cancer Unit through filtering the completion time of the tests, and all results were evaluated without sampling. Thus, data were presented using descriptive statistics. Results The mean age of 89,302 women included in the cervical cancer screening program was 45.9 ± 9.0 years. Of the samples obtained from the participants, 1.0% were determined as insufficient material, 94.1% as HPV-negative, and 4.9% as HPV-positive. The most common HPV genotypes were 16, 51, 31, and 52. Of the 4337 HPV-positive women, 74.7% of the pap smear results were negative (including infection, 36.5%), and the most common premalignant lesions were atypical squamous cells of undetermined significance in 7.1% and low-grade squamous intraepithelial lesions in 6.9%. HPV 16/18 was also observed in 31.7% of HPV-positive women. Seven hundred ninety-five women were referred to a specialist physician for further examination and treatment within the scope of the screening algorithm. Conclusion Detecting HPV-positivity by reaching more women within the national cervical cancer screening program’s scope is vital in fighting against this disease. The effectiveness of cancer screening programs should be increased by ensuring community participation through awareness activities.
first_indexed 2024-04-11T21:34:25Z
format Article
id doaj.art-ebef3e617e4e4040b69b3d8bee580259
institution Directory Open Access Journal
issn 1472-6874
language English
last_indexed 2024-04-11T21:34:25Z
publishDate 2022-08-01
publisher BMC
record_format Article
series BMC Women's Health
spelling doaj.art-ebef3e617e4e4040b69b3d8bee5802592022-12-22T04:01:49ZengBMCBMC Women's Health1472-68742022-08-012211810.1186/s12905-022-01916-6Results from a cervical cancer screening program in Samsun, TurkeyHatice Nilden Arslan0Muhammet Ali Oruc1Department of Public Health, Faculty of Medicine, Ondokuz Mayis UniversityDepartment of Family Medicine, Faculty of Medicine, Ahi Evran UniversityAbstract Background Cervical cancer is a preventable disease. This study aimed to share the results of the national cervical cancer screening program performed in primary health care institutions in Samsun between 2015 and 2019. Methods Women aged 30–65 years who were screened for cervical cancer in screening centers of Samsun between January 01, 2015, and December 31, 2019, were included in this descriptive study. The data were obtained from the automation program of the “National Human Papilloma Virus (HPV) Laboratory Application” used by the Provincial Directorate of Health Cancer Unit through filtering the completion time of the tests, and all results were evaluated without sampling. Thus, data were presented using descriptive statistics. Results The mean age of 89,302 women included in the cervical cancer screening program was 45.9 ± 9.0 years. Of the samples obtained from the participants, 1.0% were determined as insufficient material, 94.1% as HPV-negative, and 4.9% as HPV-positive. The most common HPV genotypes were 16, 51, 31, and 52. Of the 4337 HPV-positive women, 74.7% of the pap smear results were negative (including infection, 36.5%), and the most common premalignant lesions were atypical squamous cells of undetermined significance in 7.1% and low-grade squamous intraepithelial lesions in 6.9%. HPV 16/18 was also observed in 31.7% of HPV-positive women. Seven hundred ninety-five women were referred to a specialist physician for further examination and treatment within the scope of the screening algorithm. Conclusion Detecting HPV-positivity by reaching more women within the national cervical cancer screening program’s scope is vital in fighting against this disease. The effectiveness of cancer screening programs should be increased by ensuring community participation through awareness activities.https://doi.org/10.1186/s12905-022-01916-6HPVCervical cancerCancer screeningWomen’s health
spellingShingle Hatice Nilden Arslan
Muhammet Ali Oruc
Results from a cervical cancer screening program in Samsun, Turkey
BMC Women's Health
HPV
Cervical cancer
Cancer screening
Women’s health
title Results from a cervical cancer screening program in Samsun, Turkey
title_full Results from a cervical cancer screening program in Samsun, Turkey
title_fullStr Results from a cervical cancer screening program in Samsun, Turkey
title_full_unstemmed Results from a cervical cancer screening program in Samsun, Turkey
title_short Results from a cervical cancer screening program in Samsun, Turkey
title_sort results from a cervical cancer screening program in samsun turkey
topic HPV
Cervical cancer
Cancer screening
Women’s health
url https://doi.org/10.1186/s12905-022-01916-6
work_keys_str_mv AT haticenildenarslan resultsfromacervicalcancerscreeningprograminsamsunturkey
AT muhammetalioruc resultsfromacervicalcancerscreeningprograminsamsunturkey